Suppr超能文献

HIV-1 tat 通过结合 Env 刺突促进整合素介导的 HIV 向树突状细胞的传播,并与抗 HIV 抗体竞争中和作用。

HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.

机构信息

National AIDS Center, Istituto Superiore di Sanità, Rome, Italy.

出版信息

PLoS One. 2012;7(11):e48781. doi: 10.1371/journal.pone.0048781. Epub 2012 Nov 13.

Abstract

Use of Env in HIV vaccine development has been disappointing. Here we show that, in the presence of a biologically active Tat subunit vaccine, a trimeric Env protein prevents in monkeys virus spread from the portal of entry to regional lymph nodes. This appears to be due to specific interactions between Tat and Env spikes that form a novel virus entry complex favoring R5 or X4 virus entry and productive infection of dendritic cells (DCs) via an integrin-mediated pathway. These Tat effects do not require Tat-transactivation activity and are blocked by anti-integrin antibodies (Abs). Productive DC infection promoted by Tat is associated with a highly efficient virus transmission to T cells. In the Tat/Env complex the cysteine-rich region of Tat engages the Env V3 loop, whereas the Tat RGD sequence remains free and directs the virus to integrins present on DCs. V2 loop deletion, which unshields the CCR5 binding region of Env, increases Tat/Env complex stability. Of note, binding of Tat to Env abolishes neutralization of Env entry or infection of DCs by anti-HIV sera lacking anti-Tat Abs, which are seldom present in natural infection. This is reversed, and neutralization further enhanced, by HIV sera containing anti-Tat Abs such as those from asymptomatic or Tat-vaccinated patients, or by sera from the Tat/Env vaccinated monkeys. Thus, both anti-Tat and anti-Env Abs are required for efficient HIV neutralization. These data suggest that the Tat/Env interaction increases HIV acquisition and spreading, as a mechanism evolved by the virus to escape anti-Env neutralizing Abs. This may explain the low effectiveness of Env-based vaccines, which are also unlikely to elicit Abs against new Env epitopes exposed by the Tat/Env interaction. As Tat also binds Envs from different clades, new vaccine strategies should exploit the Tat/Env interaction for both preventative and therapeutic interventions.

摘要

在 HIV 疫苗开发中使用 Env 一直令人失望。在这里,我们表明,在存在具有生物活性的 Tat 亚单位疫苗的情况下,三聚体 Env 蛋白可防止病毒从进入门户传播到局部淋巴结。这似乎是由于 Tat 和 Env 刺突之间的特异性相互作用形成了一种新的病毒进入复合物,有利于 R5 或 X4 病毒进入和通过整联蛋白介导的途径对树突状细胞(DC)进行有效的感染。这些 Tat 作用不需要 Tat 反式激活活性,并且可以被抗整联蛋白抗体(Abs)阻断。Tat 促进的有效 DC 感染与高效的病毒向 T 细胞传播相关。在 Tat/Env 复合物中,Tat 的富含半胱氨酸区域与 Env 的 V3 环结合,而 Tat 的 RGD 序列仍然保持自由状态,并将病毒引导至存在于 DC 上的整联蛋白。V2 环缺失会使 Env 的 CCR5 结合区域暴露无遗,从而增加 Tat/Env 复合物的稳定性。值得注意的是,Tat 与 Env 的结合会消除缺乏抗 Tat Abs 的抗 HIV 血清对 Env 进入或 DC 感染的中和作用,而在自然感染中很少存在这种 Abs。通过包含抗 Tat Abs 的 HIV 血清(例如来自无症状或 Tat 疫苗接种患者的血清)或通过来自 Tat/Env 疫苗接种猴子的血清,这种中和作用会被逆转并进一步增强。因此,高效的 HIV 中和作用需要抗 Tat 和抗 Env Abs。这些数据表明,Tat/Env 相互作用增加了 HIV 的获得和传播,这是病毒逃避抗 Env 中和 Abs 的一种进化机制。这可能解释了基于 Env 的疫苗效果不佳的原因,这些疫苗也不太可能引发针对 Tat/Env 相互作用暴露的新 Env 表位的 Abs。由于 Tat 还结合来自不同进化枝的 Envs,因此新的疫苗策略应利用 Tat/Env 相互作用进行预防和治疗干预。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7116/3496724/ab9f2e084ef7/pone.0048781.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验